Diabetes: Insulet, DexCom rekindle partnership with mobile app for OmniPod
Insulin Management
Diabetes: Medtronic and Sanofi ally on new drug-device combinations
Diabetes: Bionic pancreas tech may give Type I diabetics some freedom, study finds
From right, researcher Dr. Steven Russell of Massachusetts General Hospital stands with Frank Spesia and Colby Clarizia, participants in a Type I diabetes trial testing an electronic device called a bionic pancreas.
Diabetes: New warnings for Medtronic’s Paradigm insulin pumps
Australian healthcare regulators issued renewed warnings to patients using Medtronic’s (NYSE:MDT) Paradigm insulin pumps, cautioning that an accidental button-press may result in a potentially dangerous overdose.
CeQur gets new CEO from Becton Dickinson | Personnel Moves
Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson’s (NYSE:BDX) diabetes arm.
Diabetes: Medtronic teams up with Aetna to tackle Type II diabetes
Diabetes: Medtronic launches i-port Advance insulin injection port
Diabetes: Insulet expands into new HQ
Tandem Diabetes slides hard on growing insulin cartridge recall
Diabetes: Insulet to hire 20 new sales reps as pediatric pump sales soar
Diabetes: Tandem recalls insulin cartridges over leak risk
